To mark International Nurses Day, Elsevier is launching Clinician of the Future 2026: Nurses Edition. We asked nurses about their use of AI, their views on AI’s future in healthcare, and what’s needed to increase trust in new technologies. Find out more.
https://t.co/fbSClqQTah
#healthcare #Elsevier #AI
Elsevier's # ClinicianoftheFuture report is based on a survey fielded between the end of 2025 and early 2026. It found 71% of nurses globally feel they have enough time with patients, compared to 60% of doctors.
https://t.co/XI2lXLWPBp
#Healthcare#Elsevier#AI
🚨😲🤷🏽♀️ NVIDIA just exposed the hidden truth about AI economics.
Bryan Catanzaro, VP of Applied Deep Learning at NVIDIA: “For my team, the cost of compute is far beyond the costs of the employees.”
While the world debates whether AI will replace humans, Big Tech is facing another reality: AI is incredibly expensive to run.
▶️ Uber reportedly exhausted its 2026 AI budget early
▶️ Big Tech is spending ~$740B on AI infrastructure this year
▶️ MIT research found humans were still cheaper in 77% of vision-based automation roles studied
The conversation is shifting from:
“Can AI replace people?” to: “Can companies afford AI at scale?”
AI may transform work. However, compute is becoming the new oil.
🤔💬 What do you think, are we underestimating the real cost of the AI revolution?
Sources:
Axios + MIT Initiative on the Digital Economy
Image: https://t.co/vUDLDoDCPm | IG (Give them a follow).
#AI #ArtificialIntelligence #NVIDIA #GenerativeAI #MachineLearning #Tech #FutureOfWork #Automation #BigTech #AITrends #Innovation #DataScience #technews
ClinicalKey AI has received the MedTech Breakthrough Award for AI Innovation for the third consecutive year!
Elsevier’s flagship clinical decision support solution was recognized for helping clinicians access trusted, evidence-based information at the point of care, with continued improvements to workflow integration, content, and traceability.
Read more: https://t.co/pX3qrP7ZKX
#Elsevier #ClinicalKeyAI #MedTech #Health
The growing burden of knowledge forces #researchers to specialize deeply, often at the cost of missing opportunities across fields. That’s why Elsevier built #LeapSpace.
It’s not just an AI tool for summarizing information, it’s designed to help researchers think critically, connect ideas, and uncover novel opportunities.
By reducing the risks of exploring new directions, LeapSpace empowers researchers to move beyond incremental work and pursue new directions that create meaningful impact.
Try LeapSpace today: https://t.co/y3mrOvnNb8
#Research #Elsevier #AI
🚀Elsevier is hiring. Ready for your next role in tech? Come and join their Mexico Tech Hub 🇲🇽. They’re on a mission to help advance science, healthcare, and technology for the benefit of society. So, they’re growing their Mexico Tech Hub and looking for talented engineers, developers, and tech innovators to join in.
💡 Why join? You’ll work on meaningful products that power research, healthcare decisions, and global knowledge sharing used by millions worldwide. This isn’t just another tech role; it’s a chance to make a real-world impact.
🔧 What they’re looking for:
They’re hiring across multiple roles, including:
• Software Engineers (Backend, Frontend, Full Stack)
• Data Engineers and Data Scientists
• Cloud and DevOps Engineers
• QA and Automation Specialists
🌍 What you’ll get:
• Work on scalable, high-impact platforms
• Collaborate with global teams in an inclusive environment
• Competitive salary and benefits
• Continuous learning and career growth opportunities
📍 Location: Mexico
If you’re passionate about building technology that matters and want to be part of a purpose-driven company, join in.
👉 Apply now: https://t.co/v2yXm3iKTZ
#TechJobs #Hiring #MexicoTech #SoftwareEngineering #DataJobs #Elsevier #Innovation #Technology
🚨🧬👏🏾 A potential game-changer for diabetes treatment may be unfolding in China. Researchers have reported promising progress using stem cell-derived islet therapy to help diabetes patients produce insulin naturally again.
In early clinical studies, some patients with severe diabetes showed:
✅ Improved insulin production
✅ Better blood sugar regulation
✅ Reduced dependence on external insulin support
✴️ Let’s be clear, scientists are NOT calling this a cure yet. The therapy remains experimental and requires larger, long-term trials before it can become mainstream treatment. However, this matters. Why? This is because regenerative medicine is shifting healthcare from “managing symptoms” to potentially repairing damaged biological function itself.
For the millions living with Type 1 and Type 2 diabetes worldwide, breakthroughs like this represent more than science. They represent hope.
One of the most remarkable aspects is that researchers are exploring ways to regenerate insulin-producing cells rather than relying solely on lifelong management.
If proven safe and scalable, this could redefine the future of chronic disease treatment.
Research published in The Lancet Diabetes & Endocrinology and reported by the Chinese Academy of Sciences.
💬What’s your view?
Could regenerative medicine become one of the biggest healthcare revolutions of our lifetime? 👇
Source: Chinese Academy of Sciences
Image: thetinderblog via dailyhappystories | IG (Give them a follow).
📌 Tags:
#Diabetes #StemCells #Healthcare #MedicalBreakthrough #Biotech #HealthTech #Science #AI #MedTech #ClinicalTrials #Type1Diabetes #Type2Diabetes #Research #Biotechnology
Two decades ago, #research output was overwhelmingly concentrated in Europe and N/America. #Researchers in low- and middle-income countries were too often cast as data collectors or junior collaborators. That position is no longer tenable.
https://t.co/KOR3BEAt7P
#Elsevier
China's #research output has risen in recent years. Despite occasional restrictions, co-authorship between Chinese and American scholars has remained surprisingly strong. #CGTN's Zhao Chenchen spoke with Arnold Pippel, SVP, Elsevier
https://t.co/kHQIuz13Pc
#Publishing#Elsevier
The need for purpose-built AI solutions that draw on trusted scientific content and data to support researchers’ critical thinking is growing.
Forbes recently highlighted LeapSpace, Elsevier’s research-grade AI-assisted workspace that helps academic and corporate scientists uncover deeper insights, accelerate innovation, and collaborate seamlessly in a single secure environment.
Read the article: https://t.co/IFDwJDt2QE
#LeapSpace #Research #Researchers #Elsevier